Kadcyla® 160mg Injection (Trastuzumab Emtansine) – Targeted Therapy (Rx)
₨166,080.00
Additional information
| Generic Name | Trastuzumab Emtansine |
|---|---|
| Strength | 160 mg |
| Dosage Form | Powder for concentrate for solution for infusion |
| Manufacturer | F. Hoffmann-La Roche Ltd |
| Storage | 2–8°C, do not freeze |
| Prescription | Prescription only (Rx) |
Quick answer: Kadcyla 160mg contains trastuzumab emtansine (T-DM1), a targeted medicine for HER2-positive breast cancer. It joins the antibody trastuzumab to a chemotherapy drug, so the treatment reaches the cancer cells directly. A nurse gives it as a drip every three weeks. MedHub supplies it on prescription across Pakistan.
Patient and caregiver information
What is Kadcyla 160mg?
Kadcyla is Roche’s brand of trastuzumab emtansine. Doctors call this type of medicine an antibody-drug conjugate. The antibody part finds the HER2 protein on breast cancer cells, and the chemotherapy part attached to it works inside those cells. This 160mg vial contains a powder that the hospital pharmacy mixes and dilutes before your infusion.
What is it used for?
Oncologists prescribe Kadcyla for HER2-positive breast cancer in two situations:
- Early breast cancer: after surgery, when some cancer remained in the breast or lymph nodes despite treatment given before the operation.
- Advanced (metastatic) breast cancer: after earlier treatment with trastuzumab and a taxane chemotherapy.
Kadcyla helps only when a tumour test shows HER2-positive disease, so your doctor confirms this first.
How is it given?
Kadcyla 160mg is given by trained healthcare staff in a hospital or clinic, as an injection or infusion. Your doctor decides the dose and the treatment schedule.
Common side effects
- Tiredness, headache and muscle or joint aches
- Nausea and constipation
- Nosebleeds or bleeding gums, linked to a low platelet count
- Changes in liver blood tests
Your team checks your blood, liver and heart regularly during treatment. Call your doctor straight away if you notice yellow skin or eyes, heavy bleeding, breathlessness, swollen ankles or a racing heart.
Storage and transportation
Transportation of cold-chain products must go through the dispensing pharmacy and follow the manufacturer’s instructions. Ask your dispensing pharmacist if you have any questions about handling.
How to order from MedHub
- Send a photo of your prescription on WhatsApp.
- Our pharmacist confirms the price and stock with you.
- We pack the vial in a cold-chain box and deliver it to your city or hospital.
Families abroad often arrange Kadcyla for family in Pakistan through us. You can also look at Herceptin 440mg (trastuzumab) and Herceptin 600mg, or browse all oncology medicines.
For healthcare professionals
- Composition: trastuzumab emtansine 160 mg, lyophilised powder for concentrate for solution for infusion (single-dose vial)
- Drug class: HER2-directed antibody-drug conjugate (trastuzumab linked to the microtubule inhibitor DM1)
- Indications: HER2-positive early breast cancer with residual invasive disease after neoadjuvant taxane and HER2-targeted therapy; HER2-positive unresectable locally advanced or metastatic breast cancer previously treated with trastuzumab and a taxane
- Mechanism: binds HER2, is internalized, and releases DM1 inside the cell, causing cell cycle arrest and apoptosis; retains the anti-HER2 activity of trastuzumab
- Label dose: 3.6 mg/kg IV every 3 weeks; first infusion over 90 minutes, later infusions over 30 minutes if well tolerated; do not exceed 3.6 mg/kg
- Important: not interchangeable with trastuzumab; do not substitute
- Monitoring: LVEF at baseline and regularly; liver function and platelet count before each dose
- Storage: 2–8°C; do not freeze
- Manufacturer: F. Hoffmann-La Roche Ltd, Switzerland
- Marketed in Pakistan by: Roche Pakistan Ltd
- Pack: 1 vial
Frequently asked questions
What is Kadcyla 160mg?
Kadcyla is Roche's brand of trastuzumab emtansine.
What is Kadcyla 160mg used for?
Kadcyla 160mg treats HER2-positive breast cancer. Doctors use it after surgery when some cancer remains, and for advanced breast cancer that has already been treated with trastuzumab and a taxane.
How is Kadcyla 160mg given?
Kadcyla 160mg is given by trained healthcare staff in a hospital or clinic, as an injection or infusion. Your doctor decides the dose and the treatment schedule.
How does Kadcyla 160mg work?
Kadcyla 160mg combines the antibody trastuzumab with a chemotherapy medicine called DM1. The antibody part travels through the bloodstream and attaches to HER2 receptors on breast cancer cells. The cell then pulls the medicine inside, where DM1 is released. DM1 disrupts the tiny tubes that cells need to divide, so the cancer cell dies. The antibody part also blocks HER2 growth signals.
What precautions should I know before using Kadcyla 160mg?
Before treatment, tell your doctor about any heart disease, liver problems, lung disease, low platelets, bleeding problems or use of blood thinners. It is a different medicine from plain trastuzumab, and the two cannot be swapped. Use effective contraception during treatment and for seven months afterwards, and do not breastfeed. Report straight away yellow skin, dark urine, breathlessness, a cough, swollen ankles, nosebleeds or other unusual bleeding, or numbness in the hands or feet.
What is the Kadcyla 160mg price in Pakistan?
Kadcyla 160mg costs Rs 166,080 per vial. Contact MedHub to confirm current price, availability and delivery options.
Can I get Kadcyla 160mg in Lahore, Karachi or Peshawar?
Yes. MedHub serves patients across Pakistan, including Islamabad, Rawalpindi, Lahore, Karachi, Peshawar, Multan and Faisalabad. Contact MedHub to confirm current price, availability and delivery options.
Do I need a prescription to buy Kadcyla 160mg?
Yes. Kadcyla 160mg is a prescription-only medicine. Send a clear photo of your doctor's prescription on WhatsApp, and our pharmacist checks it before confirming your order.
Can I order Kadcyla 160mg for my family in Pakistan from abroad?
Yes. People in the UAE, UK and Saudi Arabia order Kadcyla 160mg through MedHub for their family in Pakistan. Share the prescription on WhatsApp, and our team guides you through payment and delivery to their home or hospital.
Sources: FDA prescribing information for healthcare professionals. MedHub writes its own plain-language summaries. Always read the leaflet supplied with your medicine.
Questions about your treatment or outcome? Consult your doctor.
Questions about this medicine, availability or price? Consult our pharmacist on WhatsApp or call 0333 4575527.
This information is for general awareness only and is not medical advice. Always consult your doctor before starting, stopping or changing any medicine.












Reviews
There are no reviews yet.